University of Southern California
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Southern California sits in the top decile of US sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count).
University of Southern California: 617 sponsored US clinical trials, 97 recruiting.
University of Southern California sponsors 617 registered US clinical trials on ClinicalTrials.gov, 97 of them currently recruiting, and 361 completed. 31 of these trials are in Phase 3-4 (later-stage) and 173 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
University of Southern California ranks in the top decile of sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
361 of 466 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
617 total, page 10 of 13
Effects of Kuvan on Melatonin Secretion
NCT01617070
Behavioral Economics Incentives for Health Management
NCT01823458
Testosterone Administration and ACL Reconstruction in Men
NCT01595581
Dose Optimization for Stroke Evaluation
NCT01749358
Intra-arterial Magnesium Administration for Acute Stroke
NCT01502761
Endovascular Magnesium Sampling in Acute Stroke
NCT01502748
Nudging Guideline-concordant Antibiotic Prescribing Using Public Commitments
NCT01767064
Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma
NCT01518465
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
NCT02967380
Lubricant Versus Lidocaine Gel for Pain Control During Urodynamics
NCT01612156
Clamped or Unclamped Surgery in Treating Patients With Kidney Cancer
NCT01547676
Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic Surgery
NCT01495130
Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities
NCT01456416
Virtual Sprouts: Web-based Gardening Games to Teach Nutrition and Combat Obesity
NCT02017158
Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Main Study)
NCT01454947
Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Pilot Study)
NCT01454960
Trial to Examine Text-message Based mHealth in Emergency Department Patients With Diabetes
NCT01403831
LA Sprouts: The Impact of Gardening and Nutrition Education on Childhood Obesity in Latino Youth
NCT02291146
The HJ MILE HIV Prevention Intervention for Post-incarcerated Men
NCT01427543
Using Salsalate to Target Adipocyte Macrophage Infiltration
NCT02130804
Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder
NCT01382706
The SOLVE-IT National Randomized Trial
NCT00653991
Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer
NCT01407341
Alzheimer's Disease Neuroimaging Initiative 2
NCT01231971
Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation
NCT01318005
Social Work Intervention Focused on Transitions
NCT02232126
Oral Hydration for Mild to Moderate Hyperglycemia in the Emergency Department
NCT01401634
Use of a Microbial Sealant to Reduce Surgical Site Infections.
NCT02241915
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.
NCT01276054
Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
NCT01240629
Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Image-Guided Prostate Biopsy Following Radical Prostatectomy in Patients With Prostate Cancer
NCT01764347
MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer
NCT02578602
Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy
NCT01238965
Endoscopic Breast Surgery in Treating Patients With Breast Cancer
NCT01222377
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
NCT01219075
Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia
NCT01153919
Sequential vs. Standard Laser Treatment of Twin-twin Transfusion Syndrome
NCT02122328
Diabetes-Depression Care-management Adoption Trial
NCT01781013
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT01155258
Effects of Whole Body Vibration Exercise on Metabolic Systems in Latino Boys
NCT01635673
Etravirine Pharmacokinetics and HIV Viral Load in Breast Milk and Plasma
NCT01625169
Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer
NCT00574769
Chlorhexidine Gluconate Versus Povidone Iodine at Cesarean Delivery: a Randomized Controlled Trial
NCT01975805
Early Small Bowel Obstruction Following Laparotomy For Trauma
NCT01068340
Multi-frequency Bioelectrical Impedance for Estimating Total Body Water by Deuterium Dilution
NCT01607229
Pulse ACTH vs. MP for MS
NCT01049451
Let's Empower and Prepare Young Adults With Type 1 Diabetes
NCT02807155
Hydration Factor Study for the Stayhealthy BC3
NCT01209936
Short-Term Fasting: Impact on Toxicity
NCT00936364
Yoga Empowers Seniors Study
NCT01411059
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 83 |
| Phase 2 | 90 |
| Phase 3 | 9 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the University of Southern California pipeline
97 recruiting of 617 indexed (16% open); 361 completed (59%).
Phase mix: 31 late (III/IV) vs 173 early (I/II) (early-phase heavy).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Southern California: open-pipeline peers nationwide
Peers matched on 617 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of Southern California sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 617 trials (± recruiting share)
- Baylor College of Medicine · 616 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Rochester · 636 trials · 15% recruiting
- Janssen Research & Development · 593 trials · 11% recruiting
Sponsors near 16% open enrollment (± trial volume)
- Youngstown State University · 16% recruiting · 19 trials
- Roswell Park Cancer Institute · 16% recruiting · 365 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- University of Oregon · 16% recruiting · 63 trials
Related
What to do with this University of Southern California page
617 registered trials is a research-attention snapshot, not an endorsement of University of Southern California or any single study.
- 97 of University of Southern California's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Southern California studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Southern California pipeline card: 617 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.